Top Authors

• Most frequent coverage on IMGN

• 
  Ohad Hammer (176 followers)

  • Immunogen's Busy Month, Part II (Wed, Dec 2)
  • Immunogen's Busy Month, Part I (Tue, Dec 1)
  • Incyte: Life After Debt (Part I) (Wed, Oct 14)

  More by Ohad Hammer on IMGN »
• 
  Alan Brochstein (711 followers)

  • Cancer Stocks Hammered Once Again (Tue, Jun 26)
  • Cancer Stocks Slide Again (Mon, Jun 18)
  • Cancer Stocks Plunge Following ASCO Meeting (Mon, Jun 11)

  More by Alan Brochstein on IMGN »
• 
  Beta Delta (11 followers)

  • Immunogen: Moving on Up (Fri, Mar 27)
  • Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer (Tue, Jan 6)
  • Time to Buy ImmunoGen (Thu, Dec 4)

  More by Beta Delta on IMGN »

• Most followed authors on IMGN

• 
  Mike Havrilla (1942 followers)

  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO (Mon, Jun 1)
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches (Mon, May 18)
  • FDA, Clinical Trial Calendar Updates: AstraZeneca Announces Phase III Results (Tue, May 12)

  More by Mike Havrilla on IMGN »
• 
  Marco Hickey (1317 followers)

  • 37 Breakout Stocks on Big Volume, November 16, 2009 (Tue, Nov 17)

  More by Marco Hickey on IMGN »
• 
  J Clinton Hill (978 followers)

  • 20 'Bathwater Babies' and 3 'Dogs with Fleas' for the Week (Mon, Mar 2)

  More by J Clinton Hill on IMGN »

• Newest authors on IMGN

• 
  Justin M. Hall (672 followers)

  • December's Game Plan for Biotech (Tue, Dec 1)
  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on IMGN »
• 
  M. E. Garza (522 followers)

  • Healthcare Stocks Continue to Rise (Fri, Jun 19)

  More by M. E. Garza on IMGN »
• 
  The Burrill Report (206 followers)

  • Three Life Science Companies Line Up for IPOs (Mon, Sep 21)
  • Pharma M&A: Big Bonds and Small Deals (Fri, Jun 26)
  • A Healthy Dose of Funding for Pharma, Biotech (Sun, Jun 21)

  More by The Burrill Report on IMGN »

• Most commented on IMGN

• 
  Ohad Hammer (176 followers)

  • Immunogen's Busy Month, Part II (Wed, Dec 2)
  • Immunogen's Busy Month, Part I (Tue, Dec 1)
  • Incyte: Life After Debt (Part I) (Wed, Oct 14)

  More by Ohad Hammer on IMGN »
• 
  Justin M. Hall (672 followers)

  • December's Game Plan for Biotech (Tue, Dec 1)
  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on IMGN »
• 
  Alan Brochstein (711 followers)

  • Cancer Stocks Hammered Once Again (Tue, Jun 26)
  • Cancer Stocks Slide Again (Mon, Jun 18)
  • Cancer Stocks Plunge Following ASCO Meeting (Mon, Jun 11)

  More by Alan Brochstein on IMGN »